Prosecution Insights
Last updated: August 06, 2026

University of Ulsan Foundation for Industry Cooperation

9 pending office actions • 7 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days

Portfolio Summary

9
Total Pending OAs
5
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
3
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (56%)
4
Medium (44%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other4 (44%)
§103 only4 (44%)
Multi-statute (no §101)1 (11%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
22% of docket
0
Information Tech
0% of docket
1
Communications
11% of docket
1
Semiconductors
11% of docket
3
Mechanical / Eng
33% of docket
2
Business / Other
22% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

90 h
Manual time on pending OAs
18 h
Time saved (low, 20%)
31 h
Time saved (mid, 35%)
0.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
RAYMOND, LINNAE ELIZABETH 1 50.0% +58.9%
BORI, IBRAHIM D 1 44.2% +38.7%
NGUYEN, TRAN N 1 61.9% +16.9%
TRAN, JENNY NGAN 1 37.5% +46.7%
VOLKOV, ALEXANDER ALEXANDROVIC 1 28.4% +24.5%
YU, DELPHINUS DOU YI 1 50.0% +0.0%
HAYNES, DAWN TRINAH 1 2.7% +0.7%
LEE, DA WEI 1 76.3% +17.1%
NGO, MEAGAN N 1 58.2% +32.2%

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18438563 APPARATUS AND METHOD FOR PREDICTING HYPOTENSION BASED ON ARTERIAL PRESSURE WAVELET TRANSFORMATION, AND METHOD FOR TRAINING HYPOTENSION PREDICTION MODEL NGUYEN, TRAN N 17d overdue
18249016 PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF RETINAL OR CHOROIDAL DISEASE COMPRISING PLVAP AS ACTIVE INGREDIENT YU, DELPHINUS DOU YI 23d
18004585 APPARATUS, METHOD, AND COMPUTER-READABLE STORAGE MEDIUM FOR SELECTING CLINICAL TRIAL SUBJECT HAYNES, DAWN TRINAH 28d
18856351 ARTIFICIAL STRUCTURE FOR PREVENTING OR TREATING LYMPHEDEMA AND CONSTRUCTION METHOD THEREFOR RAYMOND, LINNAE ELIZABETH
18573608 USE OF ANTI-CITRULLINATED PEPTIDE ANTIBODY AS BIOMARKER FOR DIAGNOSIS AND PROGNOSIS OF AORTIC VALVE STENOSIS VOLKOV, ALEXANDER ALEXANDROVIC

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18438563 APPARATUS AND METHOD FOR PREDICTING HYPOTENSION BASED ON ARTERIAL PRESSURE WAVELET TRANSFORMATION, AND METHOD FOR TRAINING HYPOTENSION PREDICTION MODEL NGUYEN, TRAN N 17d overdue
18058956 NANOSTRUCTURE-BASED SUBSTRATE FOR SURFACE-ENHANCED RAMAN SPECTROSCOPY, AND MANUFACTURING METHOD THEREFOR LEE, DA WEI 4d overdue
18056766 RECTUM EXPANDING BALLOON CATHETER NGO, MEAGAN N 14d
18856351 ARTIFICIAL STRUCTURE FOR PREVENTING OR TREATING LYMPHEDEMA AND CONSTRUCTION METHOD THEREFOR RAYMOND, LINNAE ELIZABETH
18695887 PHARMACEUTICAL COMPOSITION COMPRISING CDK INHIBITOR AND ID2 ACTIVATOR FOR PREVENTION OR TREATMENT OF BLADDER CANCER BORI, IBRAHIM D
18681973 TYMPANUM IMAGE PROCESSING APPARATUS AND METHOD FOR GENERATING NORMAL TYMPANUM IMAGE BY USING MACHINE LEARNING MODEL TO OTITIS MEDIA TYMPANUM IMAGE TRAN, JENNY NGAN
18573608 USE OF ANTI-CITRULLINATED PEPTIDE ANTIBODY AS BIOMARKER FOR DIAGNOSIS AND PROGNOSIS OF AORTIC VALVE STENOSIS VOLKOV, ALEXANDER ALEXANDROVIC

Top Art Units

Art UnitApps
1629 1
3685 1
2615 1
1636 1
3686 1
2817 1
3781 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18856351 ARTIFICIAL STRUCTURE FOR PREVENTING OR TREATING LYMPHEDEMA AND CONSTRUCTION METHOD THEREFOR RAYMOND, LINNAE ELIZABETH §103§112 Non-Final OA Pending Oct 11, 2024
18695887 PHARMACEUTICAL COMPOSITION COMPRISING CDK INHIBITOR AND ID2 ACTIVATOR FOR PREVENTION OR TREATMENT OF BLADDER CANCER BORI, IBRAHIM D 1629 §103 Non-Final OA Pending Mar 27, 2024
18438563 APPARATUS AND METHOD FOR PREDICTING HYPOTENSION BASED ON ARTERIAL PRESSURE WAVELET TRANSFORMATION, AND METHOD FOR TRAINING HYPOTENSION PREDICTION MODEL NGUYEN, TRAN N 3685 §101§103 Final Rejection 17d overdue Pending Feb 12, 2024
18681973 TYMPANUM IMAGE PROCESSING APPARATUS AND METHOD FOR GENERATING NORMAL TYMPANUM IMAGE BY USING MACHINE LEARNING MODEL TO OTITIS MEDIA TYMPANUM IMAGE TRAN, JENNY NGAN 2615 §103 Final Rejection Pending Feb 07, 2024
18573608 USE OF ANTI-CITRULLINATED PEPTIDE ANTIBODY AS BIOMARKER FOR DIAGNOSIS AND PROGNOSIS OF AORTIC VALVE STENOSIS VOLKOV, ALEXANDER ALEXANDROVIC §101§103§112 Non-Final OA Pending Dec 22, 2023
18249016 PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF RETINAL OR CHOROIDAL DISEASE COMPRISING PLVAP AS ACTIVE INGREDIENT YU, DELPHINUS DOU YI 1636 §101§112 Non-Final OA 23d Pending Apr 13, 2023
18004585 APPARATUS, METHOD, AND COMPUTER-READABLE STORAGE MEDIUM FOR SELECTING CLINICAL TRIAL SUBJECT HAYNES, DAWN TRINAH 3686 §101§103 Final Rejection 28d Pending Jan 06, 2023
18058956 NANOSTRUCTURE-BASED SUBSTRATE FOR SURFACE-ENHANCED RAMAN SPECTROSCOPY, AND MANUFACTURING METHOD THEREFOR LEE, DA WEI 2817 §103 Final Rejection 4d overdue Pending Nov 28, 2022
18056766 RECTUM EXPANDING BALLOON CATHETER NGO, MEAGAN N 3781 §103 Non-Final OA 14d Pending Nov 18, 2022

Managing University of Ulsan Foundation for Industry Cooperation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month